Vault-13

Frazier Life Sciences Management, L.P.

PALO ALTO, CA · CIK 1892134 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2021 · limited partnership

$4.6bn reported value +18.2% vs Q1 2026
41positions
73.6%in top 10
6 new 8 added 2 reduced 3 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 7,679,684 $899.1m19.58% 19.58% UnchangedShares held: Q3 2025 6.8m, Q4 2025 6.8m, Q1 2026 7.7m, Q2 2026 7.7m
2 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 18,088,902 $613.0m13.35% 13.35% AddedShares held: Q3 2025 16.7m, Q4 2025 16.9m, Q1 2026 16.9m, Q2 2026 18.1m +1.1m +1,145,128 6.8%
3 ERASCA INC COM ERAS ERAS 24,975,188 $457.5m9.96% 9.96% AddedShares held: Q3 2025 22.7m, Q4 2025 22.7m, Q1 2026 24.7m, Q2 2026 25.0m +300.0k +300,000 1.2%
4 MBX BIOSCIENCES INC COM MBX MBX 6,652,013 $367.2m8.00% 8.00% UnchangedShares held: Q3 2025 6.7m, Q4 2025 6.7m, Q1 2026 6.7m, Q2 2026 6.7m
5 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 9,874,511 $258.9m5.64% 5.64% UnchangedShares held: Q3 2025 9.9m, Q4 2025 9.9m, Q1 2026 9.9m, Q2 2026 9.9m
6 TREVI THERAPEUTICS INC COM TRVI TRVI 9,939,447 $185.4m4.04% 4.04% ReducedShares held: Q3 2025 10.3m, Q4 2025 10.3m, Q1 2026 9.9m, Q2 2026 9.9m -100 -100 0.0%
7 KRYSTAL BIOTECH INC COM KRYS KRYS 481,307 $178.9m3.90% 3.90% UnchangedShares held: Q3 2025 688.5k, Q4 2025 488.5k, Q1 2026 481.3k, Q2 2026 481.3k
8 MAZE THERAPEUTICS INC COM MAZE MAZE 5,032,915 $150.2m3.27% 3.27% AddedShares held: Q3 2025 4.6m, Q4 2025 4.6m, Q1 2026 4.6m, Q2 2026 5.0m +465.6k +465,641 10.2%
9 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 12,466,489 $135.3m2.95% 2.95% UnchangedShares held: Q3 2025 12.5m, Q4 2025 12.5m, Q1 2026 12.5m, Q2 2026 12.5m
10 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 882,400 $134.8m2.94% 2.94% UnchangedShares held: Q3 2025 722.4k, Q4 2025 722.4k, Q1 2026 882.4k, Q2 2026 882.4k
11 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,548,139 $115.3m2.51% 2.51% ReducedShares held: Q3 2025 3.8m, Q4 2025 3.5m, Q1 2026 3.4m, Q2 2026 1.5m -1.9m -1,900,000 -55.1%
12 DISC MEDICINE INC COM IRON IRON 1,354,852 $99.1m2.16% 2.16% UnchangedShares held: Q3 2025 1.4m, Q4 2025 1.3m, Q1 2026 1.4m, Q2 2026 1.4m
13 CYTOKINETICS INC COM NEW CYTK CYTK 1,159,879 $98.8m2.15% 2.15% UnchangedShares held: Q3 2025 890.4k, Q4 2025 934.6k, Q1 2026 1.2m, Q2 2026 1.2m
14 DYNE THERAPEUTICS INC COM DYN DYN 3,153,082 $70.0m1.53% 1.53% UnchangedShares held: Q3 2025 2.7m, Q4 2025 3.2m, Q1 2026 3.2m, Q2 2026 3.2m
15 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 225,155 $60.1m1.31% 1.31% AddedShares held: Q3 2025 133.3k, Q4 2025 133.3k, Q1 2026 133.3k, Q2 2026 225.2k +91.8k +91,822 68.9%
16 SAVARA INC COM SVRA SVRA 9,720,852 $59.9m1.30% 1.30% UnchangedShares held: Q3 2025 11.5m, Q4 2025 9.9m, Q1 2026 9.7m, Q2 2026 9.7m
17 PARABILIS MEDICINES INC COM PBLS PBLS 1,920,805 $52.6m1.14% 1.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.9m
18 AURA BIOSCIENCES INC COM AURA AURA 7,100,000 $50.4m1.10% 1.10% AddedShares held: Q3 2025 5.1m, Q4 2025 5.1m, Q1 2026 5.1m, Q2 2026 7.1m +2.0m +2,000,000 39.2%
19 ACHIEVE LIFE SCIENCES INC COM ACHV ACHV 7,614,836 $49.7m1.08% 1.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.6m
20 VOR BIOPHARMA INC COM NEW VOR VOR 2,543,939 $46.8m1.02% 1.02% UnchangedShares held: Q3 2025 0, Q4 2025 2.5m, Q1 2026 2.5m, Q2 2026 2.5m
21 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 22,446,668 $46.7m1.02% 1.02% AddedShares held: Q3 2025 3.9m, Q4 2025 3.9m, Q1 2026 3.8m, Q2 2026 22.4m +18.6m +18,650,000 491.2%
22 TARSUS PHARMACEUTICALS INC COM TARS TARS 728,644 $45.9m1.00% 1.00% UnchangedShares held: Q3 2025 1.2m, Q4 2025 728.6k, Q1 2026 728.6k, Q2 2026 728.6k
23 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 4,009,240 $40.1m0.87% 0.87% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.0m, Q2 2026 4.0m
24 ALKERMES PLC SHS ALKS ALKS 700,647 $36.7m0.80% 0.80% UnchangedShares held: Q3 2025 700.6k, Q4 2025 700.6k, Q1 2026 700.6k, Q2 2026 700.6k
25 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 1,438,198 $36.4m0.79% 0.79% UnchangedShares held: Q3 2025 613.8k, Q4 2025 1.3m, Q1 2026 1.4m, Q2 2026 1.4m
26 ZAI LAB LTD ADR ZLAB ZLAB 1,902,320 $36.1m0.79% 0.79% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
27 MANNKIND CORP COM NEW MNKD MNKD 6,600,000 $28.1m0.61% 0.61% AddedShares held: Q3 2025 0, Q4 2025 4.2m, Q1 2026 5.9m, Q2 2026 6.6m +700.0k +700,000 11.9%
28 DESIGN THERAPEUTICS INC COM DSGN DSGN 1,809,854 $26.2m0.57% 0.57% NewShares held: Q3 2025 2.0m, Q4 2025 521.0k, Q1 2026 0, Q2 2026 1.8m
29 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,925,374 $26.1m0.57% 0.57% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.9m, Q2 2026 4.9m
30 SHATTUCK LABS INC COM STTK STTK 3,750,000 $26.0m0.57% 0.57% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.8m
31 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 1,100,000 $24.2m0.53% 0.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
32 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 1,000,000 $24.2m0.53% 0.53% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
33 LEXEO THERAPEUTICS INC COM LXEO LXEO 4,824,725 $22.5m0.49% 0.49% AddedShares held: Q3 2025 4.4m, Q4 2025 4.4m, Q1 2026 4.4m, Q2 2026 4.8m +400.0k +400,000 9.0%
34 RELAY THERAPEUTICS INC COM RLAY RLAY 1,015,693 $19.0m0.41% 0.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
35 EVOLUS INC COM EOLS EOLS 2,630,665 $18.3m0.40% 0.40% UnchangedShares held: Q3 2025 2.6m, Q4 2025 2.6m, Q1 2026 2.6m, Q2 2026 2.6m
36 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 484,782 $15.4m0.34% 0.34% UnchangedShares held: Q3 2025 384.8k, Q4 2025 384.8k, Q1 2026 484.8k, Q2 2026 484.8k
37 VALNEVA SE SPONSORED ADS VALN VALN 2,291,666 $12.0m0.26% 0.26% UnchangedShares held: Q3 2025 2.3m, Q4 2025 2.3m, Q1 2026 2.3m, Q2 2026 2.3m
38 NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 NAMSW NAMSW 500,333 $10.7m0.23% 0.23% UnchangedShares held: Q3 2025 500.3k, Q4 2025 500.3k, Q1 2026 500.3k, Q2 2026 500.3k
39 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 4,447,910 $7.1m0.15% 0.15% UnchangedShares held: Q3 2025 4.6m, Q4 2025 4.6m, Q1 2026 4.4m, Q2 2026 4.4m
40 XILIO THERAPEUTICS INC COM XLO XLO 422,505 $4.0m0.09% 0.09% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 422.5k, Q2 2026 422.5k
41 IBIO INC COM NEW IBIO IBIO 1,953,467 $3.4m0.07% 0.07% UnchangedShares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
KALVISTA PHARMACEUTICALS INC KALV KALV 4,961,108 $99.9m5.0m shares
REVOLUTION MEDICINES INC RVMD RVMD 675,686 $65.7m675.7k shares
AGIOS PHARMACEUTICALS INC AGIO AGIO 1,256,080 $42.5m1.3m shares